U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07295054) titled '3 mL Inhaled Methoxyflurane for Intrauterine Device (IUD) Insertion' on Nov. 27.
Brief Summary: Intrauterine device (IUD) insertion is a common contraceptive procedure often associated with moderate to severe pain, particularly among nulliparous individuals. Current pain management strategies, such as over-the-counter analgesics, are frequently inadequate. Methoxyflurane, a short-acting, self-administered inhaled analgesic, has been shown to provide rapid and effective pain relief in acute and procedural settings. This study aims to evaluate whether 3 mL of inhaled Methoxyflurane (via Penthrox inhaler) improves patient satisfaction ...